Published February 21, 2019
| Version v1
Journal article
Open
Casting a wider net: Immunosurveillance by nonclassical MHC molecules
Creators
- D'Souza, M. Patricia1
- Adams, Erin2
- Altman, John D.3
- Birnbaum, Michael E.4
-
Boggiano, Cesar1
-
Casorati, Giulia5
- Chien, Yueh-hsiu6
- Conley, Anthony1
-
Guiomar Eckle, Sidonia Barbara7
- Früh, Klaus8
-
Gondré-Lewis, Timothy1
- Hassan, Namir9
- Huang, Huang6
- Jayashankar, Lakshmi1
-
Kasmar, Anne G.10
- Kunwar, Nina1
- Lavelle, Judith1
- Lewinsohn, David M.8
- Moody, Branch11
- Picker, Louis8
- 1. NIAID
- 2. University of Chicago
- 3. Emory University
- 4. Massachusetts Institute of Technology
- 5. San Raffaele Scientific Institute
- 6. Stanford University
- 7. University of Melbourne
- 8. Oregon Health & Science University
- 9. Immunocore Limited
- 10. Bill & Melinda Gates Foundation
- 11. Brigham and Women's Hospital
Description
Most studies of T lymphocytes focus on recognition of classical major histocompatibility complex (MHC) class I or II molecules presenting oligopeptides, yet there are numerous variations and exceptions of biological significance based on recognition of a wide variety of nonclassical MHC molecules. These include αβ and γδ T cells that recognize different class Ib molecules (CD1, MR-1, HLA-E, G, F, et al.) that are nearly monomorphic within a given species. Collectively, these T cells can be considered "unconventional," in part because they recognize lipids, metabolites, and modified peptides. Unlike classical MHC-specific cells, unconventional T cells generally exhibit limited T-cell antigen receptor (TCR) repertoires and often produce innate immune cell-like rapid effector responses. Exploiting this system in new generation vaccines for human immunodeficiency virus (HIV), tuberculosis (TB), other infectious agents, and cancer was the focus of a recent workshop, "Immune Surveillance by Non-classical MHC Molecules: Improving Diversity for Antigens," sponsored by the National Institute of Allergy and Infectious Diseases. Here, we summarize salient points presented regarding the basic immunobiology of unconventional T cells, recent advances in methodologies to measure unconventional T-cell activity in diseases, and approaches to harness their considerable clinical potential.
Files
journal.ppat.1007567.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:de6205bf8c5aae32cfa34cb3bffd1718 |
1.2 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.ppat.1007567
- Other
- oai:uchicago.tind.io:6318